Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Gina M. Vaccaro"'
Autor:
Emerson Y. Chen, Adel Kardosh, Nima Nabavizadeh, Bryan Foster, Skye C. Mayo, Kevin G. Billingsley, Erin W. Gilbert, Christian Lanciault, Aaron Grossberg, Kenneth G. Bensch, Erin Maynard, Eric C. Anderson, Brett C. Sheppard, Charles R. Thomas Jr, Charles D. Lopez, Gina M. Vaccaro, OHSU Gastrointestinal Cancer Disease Group
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 12986-12995 (2023)
Abstract Background Neoadjuvant treatment with nab‐paclitaxel and gemcitabine for potentially operable pancreatic adenocarcinoma has not been well studied in a prospective interventional trial and could down‐stage tumors to achieve negative surgi
Externí odkaz:
https://doaj.org/article/7e8d9dc8460a49968f9cd834b3f15b44
Autor:
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B. El-Khoueiry, Bruno Sangro, Tarek E. Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M. Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Publikováno v:
Journal of Clinical Oncology. 41:1747-1757
PURPOSE To investigate the safety and efficacy of nivolumab plus cabozantinib with or without ipilimumab in patients with advanced hepatocellular carcinoma. METHODS In cohort 6 of the multicohort, open-label, phase I/II CheckMate 040 study, patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf11efcf4879d774f339045b67b1d7c5
https://doi.org/10.1200/jco.22.00972
https://doi.org/10.1200/jco.22.00972
Autor:
Luai R. Zarour, Sudarshan Anand, Kevin G. Billingsley, William H. Bisson, Andrea Cercek, Michael F. Clarke, Lisa M. Coussens, Charles E. Gast, Cristina B. Geltzeiler, Lissi Hansen, Katherine A. Kelley, Charles D. Lopez, Shushan R. Rana, Rebecca Ruhl, V. Liana Tsikitis, Gina M. Vaccaro, Melissa H. Wong, Skye C. Mayo
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 3, Iss 2, Pp 163-173 (2017)
In patients with colorectal cancer (CRC) that metastasizes to the liver, there are several key goals for improving outcomes including early detection, effective prognostic indicators of treatment response, and accurate identification of patients at
Externí odkaz:
https://doaj.org/article/a2fb9ed7dbcc4a7e9cfe57e90dde9948
Autor:
Arndt Vogel, Vaibhav Sahai, Antoine Hollebecque, Gina M Vaccaro, Davide Melisi, Raed MAl Rajabi, Andrew S Paulson, Mitesh J Borad, David Gallinson, Adrian G Murphy, Do-Youn Oh, Efrat Dotan, Daniel V Catenacci, Eric Van Cutsem, Christine F Lihou, Huiling Zhen, Luisa Veronese, Ghassan K Abou-Alfa
Publikováno v:
Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2a4606c8e7c91a9011b91365ff1ff43
https://doi.org/10.1136/gutjnl-2022-basl.69
https://doi.org/10.1136/gutjnl-2022-basl.69
Autor:
Hassan Hatoum, Charles J. Link, Nicholas N. Vahanian, Noelle K. LoConte, Lodovico Balducci, Gabriela R. Rossi, Raed Al-Rajabi, John Seng, Eugene P. Kennedy, Nicholas Nissen, Joshua Banks, Warren S. Brenner, Thomas J. George, Benjamin L. Musher, Emad Elquza, Harish Lavu, Charles J. Yeo, Benjamin E. Leiby, Andrew L. Coveler, Gina M. Vaccaro, D Brock Hewitt
Publikováno v:
Hepatobiliary Surg Nutr
Objectives To compare the efficacy and safety of algenpantucel-L (HAPa; IND# 12311) immunotherapy combined with standard of care (SOC) chemotherapy and chemoradiation to SOC chemotherapy and chemoradiation therapy alone in patients with borderline re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a242a9659f405faa3d0bf5072d91ac2
https://doi.org/10.1097/sla.0000000000004669
https://doi.org/10.1097/sla.0000000000004669
Autor:
Adel Kardosh, Matthew R. Kearney, Charles D. Lopez, Kevin G. Billingsley, Emerson Y. Chen, Thomas L. Sutton, Gina M. Vaccaro, Skye C. Mayo
Publikováno v:
Journal of Gastrointestinal Cancer
Purpose Resection of liver-only colorectal liver metastases (CRLM) with perioperative chemotherapy is potentially curative. Specific primary tumor and liver metastasis characteristics have been validated to estimate the risk of recurrence. We hypothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffa78609da714666702bff1334e5bc23
http://europepmc.org/articles/PMC7900034
http://europepmc.org/articles/PMC7900034
Autor:
Andrew L. Coveler, Martin Gutierrez, Gina M. Vaccaro, Ursa Brown-Glaberman, Juneko E. Grilley-Olson, Hedy L. Kindler, Mark Zalupski, Elisabeth I. Heath, Sarina A. Piha-Paul, Allison Wehr, Hailing Lu, Jonathan Hayman, David L Bajor
Publikováno v:
Journal of Clinical Oncology. 41:708-708
708 Background: PDAC has a 5-year survival rate of 2) and nab-paclitaxel (125 mg/m2) were given on days 1, 8, and 15 and SEA-CD40 (10 or 30 µg/kg) was given on day 3 of each 28-day cycle. Pembro (400 mg) was given every 6 weeks starting on day 8 for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fafa195ea88b6a4241a8ede24ea67ab
https://doi.org/10.1200/jco.2023.41.4_suppl.708
https://doi.org/10.1200/jco.2023.41.4_suppl.708
Autor:
Kristina Hoot Young, Andrew J Gunderson, Miranda Gilchrist, Mark Whiteford, Maria X Kiely, Amanda Hayman, David P O'Brien, Rehan Ahmad, Jeffrey V Manchio, Evelyn Brosnan, Gina M. Vaccaro, Rui Li, Miklos Simon, Mary McCormick, Ashley Drokin, Julie Cramer, Walter John Urba, Michael Gough, Marka R. Crittenden, Tomoko Yamazaki
Publikováno v:
Journal of Clinical Oncology. 40:3617-3617
3617 Background: Transforming growth factor beta (TGFβ) is an immunosuppressive cytokine upregulated in colorectal cancer. Preclinical data demonstrated improved response to chemoradiation with TGFβ blockade in colorectal adenocarcinoma. Here we re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1986091186ca4f222f2e8efc73ed78ad
https://doi.org/10.1200/jco.2022.40.16_suppl.3617
https://doi.org/10.1200/jco.2022.40.16_suppl.3617
Autor:
Luis Féliz, Efrat Dotan, Arndt Vogel, Christine F. Lihou, Antoine Hollebecque, Kristen Bibeau, Daniel Virgil Thomas Catenacci, Ghassan K. Abou-Alfa, E. Van Cutsem, Davide Melisi, Andrew Scott Paulson, Mitesh J. Borad, Gina M. Vaccaro, David Gallinson, Raed Al-Rajabi, D-Y. Oh, Vaibhav Sahai, Haobo Ren, Adrian Murphy
Publikováno v:
Annals of Oncology. 32:S203-S204
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc885617aa338863e8629d552ec75ca9
https://doi.org/10.1016/j.annonc.2021.05.028
https://doi.org/10.1016/j.annonc.2021.05.028
Autor:
Gina M. Vaccaro, Yung-Jue Bang, Julien Taieb, Zev A. Wainberg, Markus Moehler, Matthew R. Silver, Janet Hong, Arinilda Silva Campos Bragagnoli, Marina Nechaeva, Min Hee Ryu, Huiling Xiong, Toshimi Takano, Sara Lonardi, Narikazu Boku, Mustafa Ozguroglu, Howard Safran, Alina Muntean, Rachel Wong, Mikhail Dvorkin, Antonio Cubillo Gracian, Hasan Şenol Coşkun
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 39, iss 9
PURPOSE The role of maintenance therapy for gastric (GC) or gastroesophageal junction cancer (GEJC) is unclear. We investigated avelumab (anti–programmed death ligand-1 [PD-L1]) maintenance after first-line induction chemotherapy for GC/GEJC. PATIE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88bcf5ad87c4529e3af596d371583156
https://pubmed.ncbi.nlm.nih.gov/33197226
https://pubmed.ncbi.nlm.nih.gov/33197226